Search Results - Jessica A. Minott

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in Mice by Lily Chan, Yeganeh Mehrani, Jessica A. Minott, Byram W. Bridle, Khalil Karimi

    Published in Vaccines (2023-10-01)
    Get full text
    Article


  2. 2

    The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy by Jessica A. Minott, Jacob P. van Vloten, Lily Chan, Yeganeh Mehrani, Byram W. Bridle, Khalil Karimi

    Published in Cells (2022-09-01)
    Get full text
    Article


  3. 3

    The Roles of Neutrophils in Cytokine Storms by Lily Chan, Negar Karimi, Solmaz Morovati, Kasra Alizadeh, Julia E. Kakish, Sierra Vanderkamp, Fatemeh Fazel, Christina Napoleoni, Kimia Alizadeh, Yeganeh Mehrani, Jessica A. Minott, Byram W. Bridle, Khalil Karimi

    Published in Viruses (2021-11-01)
    Get full text
    Article


  4. 4

    Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy by Jacob P. van Vloten, Jessica A. Minott, Thomas M. McAusland, Joelle C. Ingrao, Lisa A. Santry, Grant McFadden, James J. Petrik, Byram W. Bridle, Sarah K. Wootton

    Get full text
    Article


  5. 5

    Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration by Lily Chan, Kasra Alizadeh, Kimia Alizadeh, Fatemeh Fazel, Julia E. Kakish, Negar Karimi, Jason P. Knapp, Yeganeh Mehrani, Jessica A. Minott, Solmaz Morovati, Amira Rghei, Ashley A. Stegelmeier, Sierra Vanderkamp, Khalil Karimi, Byram W. Bridle

    Published in Vaccines (2021-09-01)
    Get full text
    Article


  6. 6

    Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer by Jessica A. Minott, Jacob P. van Vloten, Jake G.E. Yates, Lisa A. Santry, Kathy Matuszewska, Madison Pereira, Melanie M. Goens, Alicia M. Viloria-Petit, Geoffrey A. Wood, Khalil Karimi, James J. Petrik, Byram W. Bridle, Sarah K. Wootton

    Published in Molecular Therapy: Oncolytics (2023-12-01)
    Get full text
    Article


  7. 7

    Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer by Jacob P van Vloten, Kathy Matuszewska, Mark A A Minow, Jessica A Minott, Lisa A Santry, Madison Pereira, Ashley A Stegelmeier, Thomas M McAusland, Elaine M Klafuric, Khalil Karimi, Joseph Colasanti, D Grant McFadden, James J Petrik, Byram W Bridle, Sarah K Wootton

    Published in Journal for ImmunoTherapy of Cancer (2022-03-01)
    Get full text
    Article


  8. 8

    AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian C... by Ashley A. Stegelmeier, Lisa A. Santry, Matthew M. Guilleman, Kathy Matuszewska, Jessica A. Minott, Jacob G. E. Yates, Brenna A. Y. Stevens, Sylvia P. Thomas, Sierra Vanderkamp, Kiersten Hanada, Yanlong Pei, Amira D. Rghei, Jacob P. van Vloten, Madison Pereira, Brad Thompson, Pierre P. Major, James J. Petrik, Byram W. Bridle, Sarah K. Wootton

    Published in Biomedicines (2022-02-01)
    Get full text
    Article


Search Tools: